# CYCLOBENZAPRINE HYDROCHLORIDE
> **ANDA214732** · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2024-08-27
## Drug
- **FDA Application Number:** ANDA214732
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CYCLOBENZAPRINE HYDROCHLORIDE
- **Generic name:** Cyclobenzaprine Hydrochloride
- **Active ingredients:** CYCLOBENZAPRINE HYDROCHLORIDE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVAST LABS
- **First approval:** 2024-08-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214732)
---
*AI Analytics · CC0 1.0*